Prasugrel | List of Frontiers open access articles

Systematic Review

Published on 09 Jun 2022

Impact of Prasugrel and Ticagrelor on Platelet Reactivity in Patients With Acute Coronary Syndrome: A Meta-Analysis

in Cardiovascular Therapeutics

Lulu Dai
Jiawei Xu
Yuerong Jiang
Keji Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.905607

4,354 views
6 citations

Clinical Trial

Published on 25 Oct 2017

Comparative Long-Term Effect of Three Anti-P2Y12 Drugs after Percutaneous Angioplasty: An Observational Study Based on Electronic Drug Adherence Monitoring

in Drugs Outcomes Research and Policies

Valentina Forni Ogna
Isabelle Bassi
Isabelle Menetrey
Olivier Muller
Eric Tousset
Pierre Fontana
Eric Eeckhout
Chin B. Eap
Bernard Vrijens
Michel Burnier

Frontiers in Pharmacology

doi 10.3389/fphar.2017.00738

4,088 views
4 citations

Original Research

Published on 13 Dec 2021

Effects of Clopidogrel, Prasugrel and Ticagrelor on Microvascular Function and Platelet Reactivity in Patients With Acute Coronary Syndrome Undergoing Coronary Artery Stenting. A Randomized, Blinded, Parallel Group Trial

in Coronary Artery Disease

Boris Schnorbus
Kerstin Jurk
Karl J. Lackner
Caroline Welk
Thomas Münzel
Tommaso Gori

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.780605

4,371 views
2 citations

Systematic Review

Published on 28 Apr 2022

Early vs. Delayed Initiation of Treatment With P2Y12 Inhibitors in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

in Atherosclerosis and Vascular Medicine

Lourdes Vicent
Carlos Diaz-Arocutipa
Giuseppe Tarantini
Marco Mojoli
Adrian V. Hernandez
Héctor Bueno

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.862452

5,168 views
5 citations

Systematic Review

Published on 30 Sep 2022

Comparative efficacy and safety of antiplatelet or anticoagulant therapy in patients with chronic coronary syndromes after percutaneous coronary intervention: A network meta-analysis of randomized controlled trials

in Drugs Outcomes Research and Policies

Yaowang Lin
Zhigang Cai
Shaohong Dong
Huadong Liu
Xinli Pang
Qiuling Chen
Jie Yuan
Qingshan Geng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.992376

5,238 views
6 citations

Original Research

Published on 03 Jan 2024

Clopidogrel, ticagrelor, prasugrel or an alternation of two P2Y12 in patients with acute myocardial infarction with cardiogenic shock

in General Cardiovascular Medicine

Vojko Kanic
Gregor Kompara

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1266127

2,476 views
3 citations

Review

Published on 10 Jun 2021

Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review

in Stroke

Adel Alhazzani
Poongothai Venkatachalapathy
Sruthi Padhilahouse
Mohan Sellappan
Murali Munisamy
Mangaiyarkarasi Sekaran
Amit Kumar

Frontiers in Neurology

doi 10.3389/fneur.2021.667234

10,580 views
17 citations

Original Research

Published on 24 Jun 2025

Use of p48 flow diverters with hydrophilic polymer coating under prasugrel single antiplatelet therapy for intracranial aneurysms arising from small-caliber vessels (≤ 2 mm): case series, complication, and occlusion rates

in Endovascular and Interventional Neurology

Ali Khanafer
Pablo Albiña Palmarola
Kamran Hajiyev
Philip von Gottberg
Andrei Filioglo
Michael Forsting
Hans Henkes

Frontiers in Neurology

doi 10.3389/fneur.2025.1605808

1,903 views
1 citation

Systematic Review

Published on 09 Jan 2023

Efficacy and safety outcomes of long-term anti-thrombotic treatment of chronic coronary artery disease: A systematic review and network meta-analysis

in Coronary Artery Disease

Nayrouz Adawi
Victoria Rotshild
Stav Yanko
Mohammad Mowaswes
Offer Amir
Gal Haitner
Ilan Matok
Bruria Hirsh Raccah

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1016390

3,669 views

Mini Review

Published on 20 Oct 2022

Reduction or de-escalation of dual antiplatelet therapy intensity or duration in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A mini-review

in Thrombosis and Haemostasis

Mohamed Farag
Visvesh Jeyalan
Jose Luis Ferreiro
Young-Hoon Jeong
Tobias Geisler
Diana A. Gorog

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1018649

3,702 views
2 citations

Review

Published on 10 Nov 2022

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how

in Coronary Artery Disease

Marie Muthspiel
Christoph C. Kaufmann
Achim Leo Burger
Benjamin Panzer
Freek W. A. Verheugt
Kurt Huber

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.1008194

4,619 views
3 citations

Review

Published on 23 Aug 2022

Evaluation of race and ethnicity disparities in outcome studies of CYP2C19 genotype-guided antiplatelet therapy

in Coronary Artery Disease

Anh B. Nguyen
Larisa H. Cavallari
Joseph S. Rossi
George A. Stouffer
Craig R. Lee

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.991646

9,485 views
41 citations

Review

Published on 10 Nov 2023

Drugs for spontaneous coronary dissection: a few untrusted options

in Coronary Artery Disease

Ivan Ilic
Anja Radunovic
Stefan Timcic
Natalija Odanovic
Dragana Radoicic
Natasa Dukuljev
Gordana Krljanac
Petar Otasevic
Svetlana Apostolovic

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1275725

12,813 views
14 citations

Review

Published on 03 Dec 2019

Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing

in Atherosclerosis and Vascular Medicine

Małgorzata Ostrowska
Jacek Kubica
Piotr Adamski
Aldona Kubica
Ceren Eyileten
Marek Postula
Aurel Toma
Christian Hengstenberg
Jolanta M. Siller-Matula

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2019.00176

9,238 views
28 citations

Systematic Review

Published on 06 Apr 2023

Antithrombotic regimens for the prevention of major adverse cardiac events in chronic coronary syndrome: A systematic review and network meta-analysis

in Coronary Artery Disease

Gustavo Lenci Marques
Arthur Mendonça Albuquerque
Gabriela Romaniello
Fernanda Proença Lepca Bozzi
Gustavo Pereira da Cunha
Gabriel Savogin Andraus
Gabriel Hastreiter
Barbara Maniesi
Cristina Baena
Murilo Guedes

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1040936

5,453 views
5 citations

Clinical Trial

Published on 19 Apr 2024

Inflammation and platelet reactivity during adjunctive colchicine versus aspirin in patients with acute coronary syndrome treated with potent P2Y12 inhibitor

in Precision Medicine

Seung-Yul Lee
Jae Young Cho
Diana A. Gorog
Dominick J. Angiolillo
Kyeong Ho Yun
Jong-Hwa Ahn
Jin-Sin Koh
Yongwhi Park
Seok-Jae Hwang
Jin-Yong Hwang

Frontiers in Medicine

doi 10.3389/fmed.2024.1349577

2,587 views
3 citations

Articles

Impact of Prasugrel and Ticagrelor on Platelet Reactivity in Patients With Acute Coronary Syndrome: A Meta-Analysis

Comparative Long-Term Effect of Three Anti-P2Y12 Drugs after Percutaneous Angioplasty: An Observational Study Based on Electronic Drug Adherence Monitoring

Effects of Clopidogrel, Prasugrel and Ticagrelor on Microvascular Function and Platelet Reactivity in Patients With Acute Coronary Syndrome Undergoing Coronary Artery Stenting. A Randomized, Blinded, Parallel Group Trial

Early vs. Delayed Initiation of Treatment With P2Y12 Inhibitors in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Comparative efficacy and safety of antiplatelet or anticoagulant therapy in patients with chronic coronary syndromes after percutaneous coronary intervention: A network meta-analysis of randomized controlled trials

Clopidogrel, ticagrelor, prasugrel or an alternation of two P2Y12 in patients with acute myocardial infarction with cardiogenic shock

Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review

Use of p48 flow diverters with hydrophilic polymer coating under prasugrel single antiplatelet therapy for intracranial aneurysms arising from small-caliber vessels (≤ 2 mm): case series, complication, and occlusion rates

Efficacy and safety outcomes of long-term anti-thrombotic treatment of chronic coronary artery disease: A systematic review and network meta-analysis

Reduction or de-escalation of dual antiplatelet therapy intensity or duration in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A mini-review

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how

Evaluation of race and ethnicity disparities in outcome studies of CYP2C19 genotype-guided antiplatelet therapy

Drugs for spontaneous coronary dissection: a few untrusted options

Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing

Antithrombotic regimens for the prevention of major adverse cardiac events in chronic coronary syndrome: A systematic review and network meta-analysis

Inflammation and platelet reactivity during adjunctive colchicine versus aspirin in patients with acute coronary syndrome treated with potent P2Y12 inhibitor

Use of p48 flow diverters with hydrophilic polymer coating under prasugrel single antiplatelet therapy for intracranial aneurysms arising from small-caliber vessels (≤ 2 mm): case series, complication, and occlusion rates